Search Results for "Warfarin In Vte"

05:01 EST 26th November 2014 | BioPortfolio

Original Source: Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes.

INTRODUCTION: Few studies have investigated current practices in the USA relating to warfarin use and monitoring, or the effects of warfarin discontinuation on risk of venous thromboembolism (VTE) and bleeding complications. This study investigated the effect of warfarin discontinuation on rates of VTE recurrence in a real-world setting. METHODS: Integrated Healthcare Information Services database records from January 2003 to September 2007 from patients aged at least 18 years, hospitalized for VTE, and wit...

Matching Channels

Vitamin K

Vitamin K is a group of 2-methilo-naphthoquinone derivatives. There are three notable forms of vitamin K; K1 which can be synthesized by plants, K2 which can be formed by natural bacteria in the int...

Matching News

Return to Warfarin Okay After TBI?

(MedPage Today) -- Restarting warfarin (Coumadin) after a traumatic brain injury (TBI) improved overall outcomes despite the bleeding risk, an observational Medicare study showed.

Reasons for Warfarin Discontinuation in ORBIT-AF

Delve into the real reasons for stopping warfarin in patients with atrial fibrillation. American Heart Journal

Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation

To the Editor Dr Carrero and colleagues evaluated the influence of chronic kidney disease (CKD) on the efficacy and safety of warfarin therapy in a population with atrial fibrillation and recent myoca...

Stroke Rounds: APOE Tied to Warfarin Brain Bleeds (CME/CE)

(MedPage Today) -- Apolipoprotein E gene variants epsilon-2 and epsilon-4 were strong risk factors for warfarin-induced intracerebral hemorrhage independent of the drug's anticoagulant effect.

Increased Stroke Risk Caused by Warfarin?

An increase in stroke risk supports the theory of a transient hypercoagulable state at the start of warfarin treatment in patients with atrial fibrillation. Medscape Neurology

Stroke Rounds: No Help From Genotype-Guided Warfarin Dosing

(MedPage Today) -- Using a patient?s genotype to guide the initial dosing of warfarin or its analogues does not appear to be better than dosing based on clinical characteristics, a meta-analysis showe...

INR variability predicts warfarin adverse effects

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality a...

Top stories in health and medicine, August 7, 2014

From MedPage Today: Return to Warfarin Okay After TBI? Restarting warfarin (Coumadin) after a traumatic brain injury (TBI) improved overall outcomes despite the bleeding risk. Dietitians Take Aim at ...

Matching PubMed Articles

Antithrombin Levels Are Unaffected by Warfarin Use.

Context.-The results of studies among patients with antithrombin deficiency have suggested that the use of warfarin will increase the level of antithrombin. Objective.-To reevaluate the effect of warf...

Acute warfarin toxicity: An unanticipated consequence of amoxicillin/clavulanate administration.

Patient: Male, 53 Final Diagnosis: Acute Warfarin toxicity Symptoms: - Medication: Warfarin Clinical Procedure: - Specialty: Hematology.

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.

Warfarin is the most commonly prescribed anticoagulant drug; however, a narrow therapeutic range and a high risk of bleeding or stroke complicate its clinical use. Warfarin resistance was defined as p...

Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation.

Patients with non-valvular atrial fibrillation (NVAF) are at risk for stroke and systemic embolism (SSE), and this risk can be decreased with adjusted-dose warfarin. Warfarin, however, is cumbersome t...

Anticoagulation clinic versus a traditional warfarin management model.

Warfarin is the most commonly prescribed oral anticoagulant. The management of warfarin is challenging, and current guidelines fail to include a model to assist practitioners in optimizing therapeutic...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement